Responses
Oncolytic and local immunotherapy
Original research
Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
